News

Eli Lilly and Company ( NYSE: LLY) BofA Securities 2025 Health Care Conference Call May 15, 2025 11:40 AM ET Lucas Montarce - CFO Mike Czapar - SVP, IR ...
Bristol Myers CEO Christopher Boerner advocates global cost-sharing for drug R&D and criticizes PBMs. Read nore here.
Federal regulators have accepted Novo Nordisk’s application to produce a pill version of its injectable weight-loss ...
Because the drug changes the colour of urine, patients would know if they were in the active arm of the study if a regular placebo was used. As a result, TauRx opted to use methylthioninium ...